SUMMARY Dispersed cells from the submandibular gland of the male rat were prepared by collagenase treatment to study the mechanism by which immunoreactive tonin is secreted in vitro. Norepinephrine, epinephrine, and phenylephrine stimulated tonin release, an effect that was inhibited by phentolamine but not by propranolol, whereas isoproterenol, carbachol, histamine, and serotonin did not stimulate tonin release. The stimulatory effect elicited by a-adrenergic agonists was inhibited by both removal of Ca J+ from the medium and addition of diltiazem and nifedipine, both selective calcium channel blockers. The divalent cation ionophore A231S7 stimulated tonin release in the presence of Ca 2+ , but not in the presence of Mg J+ . Dibutyryl cyclic adenosine 3,5-monophosphate, methylisobutylxanthine, angiotensin II, and vasoactive intestinal peptide had no effect on tonin release. The apparent molecular size of immunoreactive tonin released into the medium under basal and norepinephrine-stimulated conditions was similar to that of standard tonin by gel exclusion chromatography. These data suggest that the in vitro secretion of immunoreactive tonin from rat submandibular gland is initiated by activation of a-adrenergic receptors and apparently involves a mechanism dependent not on cyclk adenosine 3,5-monophosphate, but on the influx of extracellular Ca*+. an enzyme of the serine protease family that .. acts directly on angiotensin (ANG) I, angiotensinogen (renin substrate), or a synthetic tetradecapeptide renin substrate to yield ANG II, a potent vasoconstrictive hormone. Synthesis of SMG tonin appears to be under androgenic control,'"* since levels of SMG tonin in the normal male rat exceed those in normal female rats, levels in castrated male rats fall to those in normal female rats, and levels in testosterone-treated female rats increase to levels in normal male rats. On the other hand, isoproterenol, a /3-adrenergic agonist, has been reported to stimulate release of tonin into saliva, an effect that may be mediated by intracellular cyclic adenosine 3',5'-monophosphate (cyclic Supported by grants-in-aid from the Ministry of Education, Science and Culture and the Ministry of Health and Welfare (6OA-3), Japan, and by funds from Japan Heart Foundation and Kanae Foundation.
To study the detailed mechanism by which tonin is secreted from rat SMG, we prepared SMG cells dispersed by collagenase from male rats and investigated the effects of a variety of agents on the release of immunoreactive tonin in vitro and the possible intracellular process responsible for its release.
Materials and Methods Incubation Procedure
Adult (8-10 weeks old) male Wistar rats weighing 250 to 350 g were used (Kitayama LABES, Kyoto, Japan). The SMGs were removed from two rats between 0900 and 1000 under sodium pentobarbital anesthesia. The glands were rinsed several times with ice-cold Krebs-Ringer bicarbonate buffer, pH 7.4, containing 0.2% glucose and 0.1% bovine serum albumin, and minced with curved scissors. The minced tissue was suspended in 50 ml of the buffer containing 0.2% collagenase (Type IV; Worthington Biochemical, Freehold, NJ, USA) and slowly stirred for 60 minutes at 37°C in an atmosphere of 95% O 2 , 5% CO 2 in a 250-ml suspension culture flask (Celstir; Whea-VOL. 8 , No 10, OCTOBER 1986 ton, Millville, NJ, USA). The cell preparation was centrifuged at 100 g for 5 minutes at 4°C, the supernatant was aspirated, and the cell pellet was washed three times with 50 ml of ice-cold Krebs-Ringer bicarbonate buffer. The cells then were resuspended in the buffer, and the cell count (as determined by a hemocytometer) was adjusted to 1 to 5 X 10 6 cells/ml. Aliquots (0.9 ml) of the cell suspension then were pipetted into 12 x 75-mm polystyrene tubes, and 0.1 ml of test samples dissolved in Krebs-Ringer bicarbonate buffer or of buffer alone was added to five incubation tubes.
The samples were incubated at 37 °C for 60 minutes in an atmosphere of 95% O 2 , 5% CO 2 . The suspended cells then were centrifuged, and the supernatant was removed for analysis. Cell viability, assessed by trypan blue exclusion was 90 to 95% before and after incubation.
In some experiments, Ca 2+ , Mg
2+
-free buffer was used to study the effect of divalent cations on the release of tonin. The amounts of immunoreactive tonin released into the medium were determined by specific radioimmunoassay (RIA).
Radioimmunoassay and Activity of Tonin
The tonin antibody used in the present study was raised in rabbits by repeated immunization with highly purified rat tonin (kindly supplied by Drs. G. Thibault and J. Genest, Canada) 8 as previously described. 4 As shown in Figure 1 , the antitonin serum used for RIA (final dilution, 1:10,000) did not show any cross-reactivity with mouse SMG renin (kindly supplied by Dr. K. Poulsen, Denmark), rat urinary kallikrein (kindly supplied by Drs. G. Thibault and J. Genest), or porcine pancreatic kallikrein (Sigma Chemical, St. Louis, MO, USA), while the dilution curve generated by the medium in which dispersed rat SMG cells were incubated paralleled that of standard tonin. The antiserum did not cross-react with other serine proteases nor with polypeptide hormones in RIA. 4 The RIA procedure for tonin has been described elsewhere. 4 The minimum detectable amount of tonin was 25 pg/tube, and the intra-assay and interassay coefficients of variation were 10 and 15%, respectively.
The tonin activity of some incubation media was also determined by the amount of ANG II generated from ANG I, as previously reported. 9 Before RIA for ANG II, 0.05-ml aliquots of samples were incubated with 3.9 X 10" 8 M ANG I at 37°C for 60 minutes in a total volume of 1 ml of 50 mM phosphate buffer, pH 6.8, containing 0.1% bovine serum albumin, 8 mM 8-hydroxyquinoline, 1 mM ethylenediaminetetraacetic acid, 0.1 mM phenylmethylsulfonyl fluoride, and 1 mM 2,2'-dipyridyl.
Angiotensin II Radioimmunoassay
Angiotensin was determined by RIA using rabbit anti-ANG II serum (Mitsubishi Yuka, Tokyo, Japan I-labeled ANG II from free radioligand was accomplished by the double-antibody method. The minimum detectable amount of ANG II was 1 pg/tube. The intra-assay and interassay coefficients of variation were less than 10%. Since the antibody significantly cross-reacted with ANG I, the amount of ANG II generated was obtained by subtracting the values in the control tubes containing ANG I alone from those in the tubes in which samples and ANG I were coincubated.
Gel Exclusion Chromatography
For gel exclusion chromatography, a 0.9 X 58-cm column was packed with Sephadex G-100 fine resin (Pharmacia Fine Chemicals, Uppsala, Sweden), equilibrated, and developed at 4°C with 50 mM phosphate buffer, pH 7.4, containing 77 mM NaCl (phosphate-buffered saline). Aliquots of incubation medium were applied to the column and eluted with phosphatebuffered saline at a flow rate of 8.6 ml/hr by descending flow; 0.4-ml fractions were collected.
Cross-reactivity of tonin antibody with rat urinary kallikrein, mouse submandibular gland (SMG) renin, or porcine pancreatic kallikrein (x). Dilution curve generated by incubation media (o) is compared with that of standard tonin (*). BIBo -fraction of trace binding.

Chemicals
The following agents were used for incubations: /-epinephrine, /-norepinephrine, JZ-isoproterenol, dlphenylephrine, carbachol, histamine, serotonin, and NSC* 2 dibutyryl cyclic AMP (all from Sigma); methyl isobutylxanthine (Calbiochem, La Jolla, CA, USA); ANG I, ANG II, and vasoactive intestinal peptide (Peptide Institute, Osaka, Japan); phentolamine (CEBA-Geigy, Basle, Switzerland); d/-propranolol (ICI, Manchester, England); A23187 (Eli Lilly, Indianapolis, IN, USA); diltiazem (Tanabe Pharmaceutical, Osaka, Japan); and nifedipine (Bayer Pharmaceutical, Leverkusen, West Germany). None of these drugs affected the viability of the dispersed cells or interfered with the RIA.
Statistics
Statistical significance of the differences between group means was tested using Student's t test. Values are presented as means ± SEM.
Results
There was a significant (p<0.01) correlation between values determined by RIA and those of tonin activity as measured by ANG U generation in the same samples; the coefficient of correlation (r) was 0.928 (n = 23). Basal release of immunoreactive tonin from dispersed SMG cells was 175 ± 12.2 ng/hr/10* cells (n = 10), while the tonin activity in terms of ANG II generated from ANG I was 24.6 ± 1.7 pmol/hr/10 6 cells. Therefore, the immunoreactive tonin released into the medium represents an active enzyme capable of cleaving ANG I into ANG II.
As shown in Table 1 , both norepinephrine and epi- nephrine stimulated the release of tonin from dispersed SMG cells incubated in vitro. Phenylephrine, an a-adrenergic agonist, also significantly stimulated secretion of tonin in a dose-dependent manner (10^-10~*M; Figure 2 ), whereas isoproterenol, a /3-adrenergic agonist, had no effect on its release (see Table 1 ). Phentolamine, an a-adrenergic antagonist, completely blocked norepinephrine-stimulated tonin release, while it had no effect on basal release ( Figure  3 ). Propranolol, a /J-adrenergic antagonist, failed to affect either basal or norepinephrine-induced tonin release (data not shown).
Removal of Ca 2+ from the incubation medium had little effect on basal tonin release (Figure 4) . Whereas both norepinephrine (10~5 M) and phenylephrine (10~* M) significantly stimulated tonin release in the presence of Ca 2+ , removal of Ca 2+ from the incubation medium abolished their stimulatory effect (see Figure  4 ). Diltiazem (1(H M) and nifedipine (10^ M), which are selective calcium channel blockers, inhibited the norepinephrine-stimulated tonin release but had little effect on basal release ( Figure 5 ). The divalent cation ionophore A23187 significantly stimulated the release of tonin in concentrations ranging between 5 and 10 /xg/ml ( Figure 6 ). This stimulatory effect was not observed in Ca 2+ , Mg 2+ -free medium; however, A23187 
. Effect of phentolamine on norepinephrine-induced immunoreactive tonin release from dispersed rat submandibular gland cells (1 x 10 6 cellslml) incubated in the absence (O) and presence of phentolamine (W), norepinephrine (U), or both drugstffl). Each column represents the mean of five incubations; bars indicate SEM. Asterisk indicates significant difference
FIGURE 4. Effect of Ca 2+ on a-agonist-induced immunoreactive tonin release from dispersed rat submandibular gland cells (4 x JO 6 eel Is/ml) incubated in the absence (a) or presence (W) of 2.5 x 10-3 M £a
2+ andlor 10~5 M norepinephrine (NOREPI) and 1(H Mphenylephrine (PHENYL). Each column represents the mean of five incubations; bars indicate SEM. Asterisk indicates significant difference (p < 0.02).
stimulated tonin release in the presence of Ca 2+ alone but not in the presence of Mg 2+ alone ( Figure 7) . Carbachol, histamine, serotonin, dibutyryl cyclic AMP, and methylisobutylxanthine failed to affect tonin release (see Table 1 ), and ANG II (100 ng/ml) and vasoactive intestinal peptide (100 ng/ml), also had no effect on tonin release (data not shown).
Gel filtration of the incubation media during basal conditions and after norepinephrine stimulation showed almost the same elution profiles: a single peak of tonin {K A = 0.33) coeluted with standard tonin with an apparent molecular weight of approximately 30,000 (Figure 8 ).
Discussion
The present study used dispersed SMG cells of the male rat to show that the immunoreactive tonin secreted in vitro is predominantly stimulated by a-adrenergic agonists, not by /3-adrenergic or cholinergic agents. These results are apparently in contrast to previous in vivo experiments in which /3-adrenergic agonist stimulated release of tonin into saliva from rat SMG. 5> 6 Compared with the in vivo studies, in which only isoproterenol was used as a stimulant for tonin release, 5 -6 the present study clearly reveals that epinephrine and norepinephrine, physiological catecholamines, as well as phenylephrine, a pure a-adrenergic agonist, are potent releasers of tonin in vitro, an effect that was blocked by phentolamine but not by propranolol. In previous in vivo experiments, despite the stimulatory effect of theophylline, a phosphodiesterase inhibitor, on tonin release, dibutyryl cyclic AMP itself had no effect. 6 Likewise, dibutyryl cyclic AMP and methylisobutylxanthine, which are potent, cell-permeable agents, had no effect on tonin release in the present in vitro studies.
The reason for this discrepancy is unknown. It may be partly accounted for by different assay methods (tonin activity vs RIA) or by different experimental designs (in vivo vs in vitro). Even though the tonin antibody used in this study did not cross-react with the various serine proteases tested, especially kallikrein, a possible cross-reactivity of the antibody with several nonkallikrein esterases in rat SMG 10 cannot be ruled out. However, in the present study, the dilution curve of the incubation medium appeared to parallel that of standard tonin and tonin correlated well with tonin activity in the same incubation media. Furthermore, the secretory form of tonin in basal and norepinephrine-stimulated conditions was similar in molecular size to standard tonin. These data suggest but do not 
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Norepmephrine(10~5M) prove that the tonin released into the medium is predominantly active.
FIGURE 5. Effect of calcium channel blockers on norepinephrine-induced immunoreactive tonin release from dispersed rat submandibular gland cells (1 x 10 6 cells/ml) incubated in the absence (a) and presence <U> of 10~3 M norepinephrine andJor 10-* M diltiazem and 10-* M nifedipine. Each column represents the mean of five incubations; bars indicate SEM. Asterisk indicates significant difference (p<0.02).
The lack of in vitro secretory response to isoproterenol may be due to preferential destruction or perturbation of /3-adrenergic receptors by proteolytic digestion because such alteration of receptor sensitivity following treatment with proteolytic enzymes has been reported." 12 Nevertheless, the functional integrity of a-adrenergic receptors in the present study argues against this possibility. Under in vivo conditions, the neural tissue may release endogenous neurotransmitters, the pericellular elements may alter the secretory response, and the metabolic changes of injected secretagogues may affect the response. In accordance with our data are those of a recent in vitro study 13 in which tonin activity was stimulated by norepinephrine but not by isoproterenol or methacholine from dispersed rat SMG cells. These in vitro data on tonin release are comparable to the stimulatory effect of a-adrenergic agonists on release of renin 14 " 16 and kallikrein 17 ' " from rat SMG.
The present in vitro results also suggest that the stimulation of tonin release by a-adrenergic receptors is calcium-dependent, since a-adrenergic stimulation of tonin release was inhibited either by removal of Ca 2+ from the medium or by the addition of selective calcium channel blockers. Furthermore, A23187, a divalent cation ionophore, mimicked the effect of a-adrenergic agonists in tonin release only when Ca 2+ was present in the medium. This finding is also comparable to the a-adrenergic-mediated calcium dependency of renin 13 and kallikrein 13 release from the rodent SMG and suggests that activation of a-adrenergic receptors leads to Ca 2+ flux into the cells, where it acts as an intracellular mediator of tonin release.
Like the renin in mouse SMG, the physiological importance of tonin in rat SMG is unknown. It has been suggested that tonin may be involved in the pathogenesis of one-kidney, one clip renovascular hypertension of animals. 19 ' x However, the involvement of tonin in experimental hypertension is controversial, as indicated by a recent report. 21 Although it has been shown that tonin is secreted into the venous effluent of the perfused rat SMG, 7 it seems unlikely that tonin plays an important role in the regulation of systemic blood pressure because of its complex formation with plasma a,-macroglobulin, a potent inhibitor of tonin. 22 On the other hand, tonin is secreted into saliva in large concentrations.*" 6 Since it has been suggested that mouse SMG renin released into saliva by aggressive behavior may be transferred by bites from one animal to another, 23 ' M rat SMG tonin may likewise be related to fighting. It is also possible that tonin may be in- VOL 8 volved in the processing of uncharacterized biologically active peptide (or peptides) in rat SMG, because the y subunit of nerve growth factor and epidermal growth factor-binding protein, which are arginine esteropeptidases with 75% sequence homology to tonin, 23 process pro-/3-nerve growth factor 26 and pro-epidermal growth factor 27 in mouse SMG, respectively. 
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